Increasing interest in targeted radionuclide therapy motivates the development of new radionuclides. The unique emission spectrum from 71Ge make it an ideal candidate for probing microdosimetric effects of low energy electrons absent confounding photon dose. This work reports a novel intermetallic target of Co and Ga for accelerator production of no-carrier-added 69/71Ge and a new method to isolate the Ge in high yields and purities.
Keywords: (69)Ge; (71)Ge; Positron emission tomography; Radionuclides; Targeted radionuclide therapy; Theranostic.
Copyright © 2022 Elsevier Ltd. All rights reserved.